naturalX secures 100 million euros

The new fund from naturalX Health Ventures supports start-ups at the interface between wellness and medicine. With a focus on preventive health solutions for the European market.

Berlin, February 17, 2025 - The healthcare industry is undergoing a profound transformation: the focus is shifting from reactive healthcare to proactive health management, where consumers are increasingly taking control of their own health. While successful consumer-centric healthcare companies such as Hims/Hers, Headspace and Function Health have already established themselves in the US, the European market remains underserved.

With the announcement of a €100 million fund, naturalX Health Ventures aims to close this gap and become the first specialized fund in Europe to invest specifically in start-ups at the interface between consumers and health.

Focus on high-growth consumer health start-ups

The fund focuses primarily on Series A investments, but remains flexible for later seed or Series B financing rounds. Initial investments are typically between 3 and 5 million euros, with the possibility to invest up to 10 million euros per company. naturalX can act as both lead and co-investor and plans to invest in European consumer health start-ups, with targeted investments in North America.

The consumer health sector has long been overlooked by investors, but we are now witnessing a turning point in Europe. Consumers are increasingly taking responsibility for their own health - and start-ups in this area need strong partners

Marvin Amberg, founder of naturalX Health Ventures

The fund was founded by Marvin Amberg, a German serial entrepreneur with experience in building consumer and health start-ups. naturalX is supported by the Schwabe Group, a global leader in the field of herbal medicines. Together, they define the term consumer health as the interplay between wellness and medicine - with science-based products and services that focus on the consumer.

During the 18-month preparation phase, naturalX has already made its first investments, including in mybacs, Flow Neuroscience, Kyan Health and Meela. In addition, investments were made in VC funds with a healthcare focus in order to build a strong ecosystem.

Rising demand for preventive healthcare solutions

The fund is launching at a crucial time: the COVID-19 pandemic has raised awareness of proactive health management, while growing health knowledge - reinforced by influencers such as Andrew Huberman, Peter Attia and Bryan Johnson - is creating more informed consumers who increasingly view health as a status symbol. In addition, easier access to health data through technology and AI is leading to increased demand for personalized health solutions.

naturalX is particularly targeting solutions in the areas of sleep, gut health, prevention and longevity. There is also a particular focus on mental health, an area with increasing demand for consumer-oriented therapeutic offerings.

Combining pharmaceutical expertise with digital innovation

The investment strategy of naturalX combines the pharmaceutical expertise of the Schwabe Group with modern digital innovations in the healthcare sector.

We have analyzed the US market and see that successful start-ups there are already focusing on the consumer. We believe that this is just the beginning and that the European market will undergo a similar development

Marvin Amberg, founder of naturalX Health Ventures

Some European companies such as Oura or Neko Health have already completed financing rounds and achieved initial scaling successes. Nevertheless, naturalX still sees great untapped potential in the European market.

Initial successes and positive feedback from portfolio companies

The first naturalX portfolio companies confirm the added value of the collaboration.

Carl-Philipp von Polheim, founder of mybacs, a leading DTC probiotics startup, says: "naturalX led our Series A round and has proven to be an exceptional partner - not only through capital, but also through in-depth market understanding and quick, pragmatic decisions that allow us to focus on our growth."

The collaboration also shows great promise in the area of mental health. Vlad Gheorghiu, founder of Kyan Health, a platform for preventive mental health solutions, explains: "naturalX shares our vision that prevention is crucial for sustainable health. Their expertise and strategic approach make them the ideal partner to bring about real change."

With the successful closing of the financing round, the fund is now fully operational and continues to expand its European investment team to actively drive the growth of consumer health startups in Europe.